Hydrochloric Acid

Hydrochloric Acid

SCHEMBL890978

CCN(CC)Cc1ccccc1.Cl

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 known ✓ Q9Y5N1 1/20 0.62
CHRM2 known ✓ P08172 1/20 0.54
HTR1A known ✓ P08908 1/20 0.54
ADRA2A known ✓ P08913 1/20 0.54
CHRM1 known ✓ P11229 1/20 0.54
DRD1 known ✓ P21728 1/20 0.54
SLC6A2 known ✓ P23975 1/20 0.54
SLC6A4 known ✓ P31645 1/20 0.54
ADRA1A known ✓ P35348 1/20 0.54
OPRM1 known ✓ P35372 1/20 0.54
DRD3 known ✓ P35462 1/20 0.54
SLC6A3 known ✓ Q01959 1/20 0.54
KCNH2 known ✓ Q12809 1/20 0.54
BCHE known ✓ P06276 1/20 0.53
MAOB known ✓ P27338 2/20 0.51
CNR2 P34972 1/20 0.61
KDM4E B2RXH2 1/20 0.60
TSHR P16473 3/20 0.58
MAPK1 P28482 1/20 0.58
ALDH1A1 P00352 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL81248 0.97 HRH3 (0.65) HRH3CNR2KDM4ETSHRMAPK1
Bromide SCHEMBL11663269 0.95 HRH3 (0.62) HRH3CNR2KDM4ETSHRMAPK1
Water SCHEMBL5507580 0.95 HRH3 (0.62) HRH3CNR2KDM4ETSHRMAPK1
Iodide SCHEMBL21693881 0.95 HRH3 (0.62) HRH3CNR2KDM4ETSHRMAPK1
Fluoride SCHEMBL11307410 0.95 HRH3 (0.62) HRH3CNR2KDM4ETSHRMAPK1
Hydrochloric Acid SCHEMBL11608574 0.95 KDM4E (0.66) HRH3CNR2KDM4ETSHRMAPK1
Chloromethane SCHEMBL27279684 0.93 HRH3 (0.60) HRH3CNR2KDM4ETSHRMAPK1
SCHEMBL8064154 0.93 HRH3 (0.60) HRH3CNR2KDM4ETSHRMAPK1
Ethylene SCHEMBL28212464 0.93 HRH3 (0.60) HRH3CNR2KDM4ETSHRMAPK1
SCHEMBL375111 0.92 KDM4E (0.68) HRH3CNR2KDM4ETSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118144394-B Release film and preparation method and application thereof 博益鑫成高分子材料股份有限公司 2024-07-09 CN claimed
CN-118144394-A Release film and preparation method and application thereof 博益鑫成高分子材料股份有限公司 2024-06-07 CN claimed
CN-110028652-A A kind of high purity epoxy resins and preparation method thereof containing biphenyl structural 上海华谊树脂有限公司 2019-07-19 CN claimed
CN-109651596-A A kind of epoxy resin and preparation method thereof containing naphthalene ring 上海华谊树脂有限公司 2019-04-19 CN claimed
CN-108101799-A A kind of high-efficient production technology of glycine 严世佳 2018-06-01 CN claimed
CN-104650311-B Self-dispersion type UV curable urethane acrylates aqueous copolymer and preparation method and its manufactured aqueous emulsion 中科院广州化学有限公司 2017-12-26 CN claimed
CN-105218401-B The method that continuity method synthesizes benzene acetonitrile 河北诚信有限责任公司 2017-08-11 CN claimed
US-20160122450-A1 SYNTHESIS OF A SUBSTITUTED FURAN AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-05-05 US claimed
CN-105218401-A The method of continuous processing synthesis benzyl cyanide Hebei chengxin co ltd 2016-01-06 CN claimed
US-9226941-B2 Two-component cleaning and disinfecting system UNION GAS CAPITAL PARTNERS, LLC 2016-01-05 US claimed
US-20150320797-A1 TWO-COMPONENT CLEANING AND DISINFECTING SYSTEM UNION GAS CAPITAL PARTNERS, LLC 2015-11-12 US claimed
CN-104650311-A Self-dispersing UV photo-curing urethane acrylate aqueous copolymer, preparation method of aqueous copolymer and aqueous emulsion prepared from aqueous copolymer CAS GUANGZHOU CHEMISTRY CO LTD 2015-05-27 CN claimed
CN-104478831-A Preparation method of triglycidyl-meta-aminophenol epoxy resin SHANGHAI HUAYI RESINS CO LTD 2015-04-01 CN claimed
EP-1981988-A2 ANTISEPTIC COMPOSITIONS AND METHODS OF USING SAME Do-Coop Technologies Ltd (IL) 2008-10-22 EP claimed
WO-2007077562-A2 ANTISEPTIC COMPOSITIONS AND METHODS OF USING SAME DO-COOP TECHNOLOGIES LTD. (IL) 2007-07-12 WO claimed
US-20020168423-A1 High strength liquid antiseptic WURZBURGER STEPHEN RAY (US) 2002-11-14 US claimed
CN-122074095-A Catalyst and method for hydrogen production by proton reduction 瑞内尔公司 2026-05-22 CN disclosed
CN-119954677-A Cyclopropionamide substituted benzamide derivative and preparation method and application thereof 山东省联合农药工业有限公司 2025-05-09 CN disclosed
US-4116866-A REACTION PRODUCT OF CASTOR-FATTY PROPYLAMIDO BENZYL DIALKYL AMMONIUM COMPOUND AND SMECTITE CLAY N L INDUSTRIES, INC. (US) 1978-09-26 US disclosed
US-3984605-A Heat sensitive recording material containing decolorizing agent MITSUBISHI PAPER MILLS, LTD. (JA) 1976-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160122450-A1 SYNTHESIS OF A SUBSTITUTED FURAN DCXR, PFAS, FUT6 HRH3 2244/4885CHRM2 4205/4885HTR1A 3408/4885
US-20020168423-A1 High strength liquid antiseptic CUTA, LIPA, POLR1C HRH3 367/4885CHRM2 3147/4885HTR1A 4543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.